Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Ritz

Showing results (241-250 of 334) with videos related to

Pageof 34
Sort By:
European Heart Journal|May 25, 2011
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failureAndreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Kidney International|April 23, 2002
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cellsOliver Vonend, Vitus Oberhauser, Ivar von Kügelgen, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephron. Experimental Nephrology|March 10, 2007
The combination of ACE inhibition plus sympathetic denervation is superior to ACE inhibitor monotherapy in the rat renal ablation modelPeter Hamar, Gabor Kokeny, Peter Liptak, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Kidney International|August 8, 2002
Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failureKerstin Amann, Johannes Törnig, Mareike Buzello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat modelsStephan R Orth, Giulio Odoni, Henryk Karkoszka, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser, Florian Kronenberg, Jan T Kielstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2009
The association between parathyroid hormone and mortality in dialysis patients is modified by wastingChristiane Drechsler, Vera Krane, Diana C Grootendorst, et al.
Pageof 34

Showing results (241-250 of 334) with videos related to

Sort By:
Pageof 34
European Heart Journal|May 25, 2011
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failureAndreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Kidney International|April 23, 2002
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cellsOliver Vonend, Vitus Oberhauser, Ivar von Kügelgen, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephron. Experimental Nephrology|March 10, 2007
The combination of ACE inhibition plus sympathetic denervation is superior to ACE inhibitor monotherapy in the rat renal ablation modelPeter Hamar, Gabor Kokeny, Peter Liptak, et al.
BMC Nephrology|October 8, 2016
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trialsGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Kidney International|August 8, 2002
Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failureKerstin Amann, Johannes Törnig, Mareike Buzello, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2002
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat modelsStephan R Orth, Giulio Odoni, Henryk Karkoszka, et al.
Journal of the American Society of Nephrology : JASN|June 3, 2005
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease studyDanilo Fliser, Florian Kronenberg, Jan T Kielstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2009
The association between parathyroid hormone and mortality in dialysis patients is modified by wastingChristiane Drechsler, Vera Krane, Diana C Grootendorst, et al.
Pageof 34